Please assess the completion status of the following clinical trial:

Trial Title: ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 50+ years of age~* Clinical suspicion for prostate cancer~* Elevated Prostate-specific Antigen between 2.0-10 ng/ mL~* At least one (1) prior negative prostate biopsy~Exclusion Criteria:~* Use of medications or hormones that are known to affect serum PSA levels within 3-6 months of study enrollment including 5-alpha-reductase inhibitors used in the treatment of an enlarged prostate gland (benign prostatic hyperplasia). Drugs in this class are finasteride (Proscar, Propecia) and dutasteride (Avodart).~* Clinical symptoms of urinary tract infection (including prostatitis) at the time of enrollment.~* History of prostate cancer.~* History of invasive treatments for benign prostatic hypertrophy (BPH) or lower urinary track symptoms within 6 months of study enrollment.~* No known hepatitis status (all types) and/or HIV documented in patient's medical record.~* Patients with history of concurrent renal/bladder tumors.

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).